02321oam 2200649 450 991071181970332120220407084718.0(CKB)5470000002487888(OCoLC)1085546440(EXLCZ)99547000000248788820190213d2019 ua 0engurbn||||a||||txtrdacontentcrdamediacrrdacarrierExamining how covered entities utilize the 340B drug pricing program hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, October 11, 2017Washington :U.S. Government Publishing Office,2019.1 online resource (iii, 184 pages) photographs"Serial No. 115-63."Includes bibliographical references.Examining how covered entities utilize the 340B drug pricing program Prescription pricingGovernment policyUnited StatesPoorPharmaceutical assistanceUnited StatesOlder peoplePharmaceutical assistanceUnited StatesOlder peoplePharmaceutical assistancefastPoorPharmaceutical assistancefastPrescription pricingGovernment policyfastUnited StatesfastLegislative hearings.fastLegislative hearings.lcgftPrescription pricingGovernment policyPoorPharmaceutical assistanceOlder peoplePharmaceutical assistanceOlder peoplePharmaceutical assistance.PoorPharmaceutical assistance.Prescription pricingGovernment policy.GPOGPOGPOMERUCTEUOCLCONKFOCLCFOCLCOTXROCLCOCOOOSOOCLCOOCLCQGPOBOOK9910711819703321Examining how covered entities utilize the 340B drug pricing program3449926UNINA